Get started
Author

Mary Nauffal

ORCID: 0000-0002-4957-6954
Observed ORCID: 0000-0002-4957-6954
OpenAlex ID: A5048925384
Nephrotoxicity of Natural Products
2016 · Mary Nauffal, Steven Gabardi · Blood Purification · 55
Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant
2021 · Mary Nauffal, Haesook T. Kim, et al. · Blood Advances · 38
PDF
Ruxolitinib resistance or intolerance in steroid‐refractory acute graft‐versus‐host disease — a real‐world outcomes analysis
2021 · Sameem Abedin, Nahid Rashid, et al. · British Journal of Haematology · 27
PDF
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium Trials
2021 · Yannis K. Valtis, Kristen E. Stevenson, et al. · Blood Advances · 14
PDF
Single 6-mg dose of rasburicase: The experience in a large academic medical center
2018 · Mary Nauffal, Robert Redd, et al. · Journal of Oncology Pharmacy Practice · 9
Abstracts
2016 · Judy Weintraub, Maria E. Ferris, et al. · Blood Purification · 7
PDF
Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration
2019 · Mary Nauffal, Lillian Werner, et al. · Leukemia Research Reports · 5
PDF
Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation
2024 · Mary Nauffal, Stephen Eng, et al. · Case Reports in Hematology · 3
PDF
Defibrotide formulations contain (1→3)-β-D-glucan that could influence clinical diagnostic testing
2020 · Sara Alosaimy, Mary Nauffal, et al. · Bone Marrow Transplantation · 2
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell Transplant
2023 · Stephen William Eng, Grashma Vadakkel, et al. · Transplantation and Cellular Therapy · 1
1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis
2019 · Muneerah Aleissa, David Kubiak, et al. · Open Forum Infectious Diseases · 1
PDF
Effect of Mycophenolate Mofetil Levels on Transplant Outcomes in Patients Treated with Post-Transplant Cyclophosphamide Based GVHD Prophylaxis
2026 · Andrew Lin, Samantha Brown, et al. · Transplantation and Cellular Therapy
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell Transplant
2025 · Stephen Eng, Grashma Vadakkel, et al. · Transplantation and Cellular Therapy
Defibrotide: Real World Experience for Management of Veno-Occlusive Disease/ Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplantation
2020 · Mary Nauffal, Haesook T. Kim, et al. · Blood
Rate of Differentiation Syndrome in Patients Based on Timing of Initial All-Trans Retinoic Acid Administration
2017 · Mary Nauffal, Lillian Werner, et al. · Blood
Title Page / Table of Contents
2016 · Judy Weintraub, Maria E. Ferris, et al. · Blood Purification
PDF
965
2013 · Gary Wu, Franklin Jeng, et al. · Critical Care Medicine
Works count: 17
Citation count: 162
H-index: 6
I10-index: 4
Year
Topic
Type